ABOUT HEALTHCARE TRENDS
The Second Edition of Healthcare Trends Expo & Summit 2025 returns with even greater momentum, gathering world-class minds from across the healthcare ecosystem. This platform will unite global leaders, innovators, clinicians, policymakers, health-tech providers, and solution seekers to collectively accelerate the future of healthcare.
In the wake of technological disruptions and evolving patient needs, this summit addresses critical global healthcare challenges by promoting collaboration, digital adoption, sustainable delivery models, and breakthrough innovation.
This year, we expand our focus to include Medical Tourism, IVF & Reproductive Health, and Oncology, recognizing their growing global impact and demand.
” Innovation is the need of the day and the disconnect
between industry and academia has to go away. “
Chief Guest
Dr. Y. K. Gupta
President – AIIMS, Bhopal, President – AIIMS, Samba
Jammu, Principal Adviser (Project), \THSTI – DBT, GOI, Chairman – Board
of Directors, BOBCOI, DBT, GOI Member General Body & Govt. Body –
National Dope, Testing Lab, GOI Bhopal
Delhi NCR, India
Telangana, India
Based on my experience I see that we have a lot of money and great opportunities in India, but we don’t want to take the risk. Unless you take a risk, you cannot innovate.
Chief Strategic Advisor
Dr. Dhileep Krishnamurthy
Chief Strategic Advisor –
Global PHT Expo & Summit 2023
Executive Advisor for Biotech,
CRAMS and Generic Industries in
USA, India & China
His views on the Impact of Process Chemistry in Healthcare Sciences. As a renowned chemist, Dr. Senanayake discussed the need to adopt green chemistry in the process of drug development for cost reduction, timely innovation, and generating less waste
than the standard process. The expertise and capabilities of TCG GreenChem were also highlighted along with TCG’s Continuous Flow Chemistry Lab (CFL) Platforms.
Keynote Speaker
Dr. Chris Senanayake
CEO TCG Green Chem
CSO TCG Life Sciences
Dr. Joe presented on the Blockbuster Drug Januvia: An Innovators Perspective. Januvia is the FIC DPP-4 inh. class that received its FDA approval in Oct’2006 for T2D. Explaining the causes and consequences of elevated blood glucose, Dr. Joe showed the high throughput screening results received from Januvia for the treatment of the disease. He also included the award winning green chemistry of Januvia and a small explanation of acceleration
value for the development of the drug.
Keynote Speaker
Dr. Joe Armstrong
COO – TCG GreenChem, Inc.
Global Head of Business Development US
Global PHT 2023 is “ Innovation, Advanced Technology, Current Challenges & Opportunities in Pharma & Healthcare Industry”. The program has already shaped up to be excellent, and the networking opportunities will be indeed outstanding and I look forward to learning the latest results from top industrial, government, and academic scientists on these topics and everything else that is presented. We are indeed in a time of great innovation in materials chemistry, so come and enjoy the research, and report your results. The program has already shaped up to be excellent, and the networking opportunities will be indeed outstanding. “
Chairman
Dr. Jagadeesh Babu Rangisetty
Chairman – Global PHT Expo & Summit-2023
CEO – Biophore India Pharmaceuticals Pvt. Ltd.
Hyderabad, Telangana, India
” These conferences are the need of the hour so that we can meet, interact, and exchange ideas and thoughts with people whom we consider as the pioneer in one or the other field or they are the innovators in their respective fields. “
Convenor
Dr. Upendra Nagaich
Convenor – Global PHT Expo & Summit – 2023
National Secretary – Society of Pharmaceutical
Education & Research (SPER)
Delhi NCR, India
India
Anytime nature hits you it gives you enough warning in advance. There is no point in facing and then reinventing a medicine on the spot that’s tough and that’s what we went through. For some reason, we did not pay attention when the SARS virus hit Singapore and at that time, we should have continued the research so that we could have been better at it globally. So, people have neglected it that’s what I would say.
Chairman – Technology
Mr. Mekala Rao
Chairman – Technology
Global PHT Expo & Summit-2023
President – Atachi Systems
California, USA
The world before and after the pandemic is not the same. We have seen a lot of challenges like a shortage of medication due to changes in demand. It not only impacted the supply chain but also the manufacturing of some molecules that were to be on the market soon, but they were delayed due to the focus on the covid. I feel the pharmaceutical industry or even the countries or governments were not ready for such a huge pandemic. So, to summarise I hope that the future will be organized to manage such crisis.
Moderator
Dr. Adel Djalal
Managing Director – Alfa Diag, UAE
Targeted Drugs for Cancer was the topic of Dr. Sumith’s talk. In giving a brief about cancer biology, he gave a comparative view of the conventional therapeutics, molecular-targeted therapeutics, and ligand-targeted therapeutics used for the treatment of cancer. Focusing on ligand-targeted therapeutics, Dr. Sumith highlighted different agents that have managed to reach clinical trials two of which had received FDA approval for the treatment of prostate cancer. Some results from the pre-clinical studies of Cytalux, EC0652/DUPA-SPECT, and EC1168/DUPA SMDC were also highlighted in the presentation.
Keynote Speaker
Dr. Sumith Kularatne
Executive VP of R&D on
Target Laboratories, LLC, USA
Past Session on Pharma Trends
Clinical Development of Biosimilars for the US and EU markets- recent regulatory updates, challenges and efficient solutions
Panellists: Dr. Y Sridhar Reddy Dr. Shubhadeep Debabrata Sinha
Effects of Lifestyle interventions on Diabetes Remission
Panelists: Dr. Anjali Nakra (Lifestyle Medicine Physician – Path to
Health clinic, India); Ms. Sheela Krishnaswamy (Nutrition & Wellness
Consultant, India); Dr. Narendra Tripathi (Head Quality Assurance
Food Safety and Regulatory Affairs – Tirupati Wellness)
Current Trends in Drugs Discovery & Healthcare
Panelists: Dr. Jacob Eswarakumar Dr. Ashok Kumar Bhattacharya Dr. Sameer Agarwal (Director – Head Medicinal Chemistry at Schrödinger, India) Dr. Gurram Kishan (Founder &MD – Sravathi AI Technology, India) Dr. Neelima Khairatkar Joshi (Founder & President – Promethean Drug Ideas, India).
Current & Future Treatment of Oncology
Panellists: Dr. Sumith Kularatne Dr. Deepa Arora Dr. Abhinav
Narwariya (Associate Consultant Medical Oncology BLK – Max Super
Speciality Hospital, India)
OUR PAST COMMITTEE
OUR PAST SPEAKERS
